All Dr Tara Crawford Parks (Director of Translational R&D and Product Enablement at DNA Genotek) articles
-
ArticleWhy first-void urine could potentially change the future of HPV screening
From richer biomarker content to patient-friendly sampling, first-void urine is emerging as a promising tool in precision health. Here is why scientists are paying attention.


